{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T17:03:50Z","timestamp":1785171830543,"version":"3.55.0"},"posted":{"date-parts":[[2026,3,31]]},"group-title":"In Review","reference-count":51,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,3,22]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  Background\n Cognitive fluctuations (CF) are a core feature of Lewy body dementia (LBD) that negatively impact quality of life. Despite their prevalence and negative impact, CF are challenging to identify clinically. The goal of this study was to identify easily obtainable EEG features associated with CF across the spectrum of Lewy body disease (LB).\nMethods\n We conducted a cross-sectional study of 53 patients prospectively enrolled through the outpatient clinics of the Department of Neurology at Virginia Commonwealth University. Based on the Clinician Assessment of Fluctuations, participants were categorized as LB disease without CF (LB-CF) or LB disease with CF (LB\u2009+\u2009CF). All participants underwent a resting-state EEG recording with eyes closed for at least 3 minutes. EEG data were preprocessed and the following features were extracted: dominant frequency (DF), dominant frequency variability (DFV), dominant frequency prevalence (DFP), and individual alpha peak frequency (IAF). We applied Kruskal-Wallis tests and logistic regression models to evaluate differences in EEG features between study groups.\nResults\n We analyzed EEG features for 29 LB\u2009+\u2009CF and 24 LB-CF participants. Compared to the LB-CF group, the LB\u2009+\u2009CF group had significantly lower DF, DFP-alpha, and IAF in all derivations (all\n                  <italic>p<\/italic>\n                  \u2009&lt;\u20090.05). In logistic regression analysis adjusting for age, sex, and MoCA score, these EEG features remained significant predictors of group (LB\u2009+\u2009CF vs. LB-CF, all\n                  <italic>q<\/italic>\n                  \u2009&lt;\u20090.05). The elastic-net logistic regression model identified five predictors (anterior DFP-alpha, anterior DFP-theta, anterior DF, temporal DF, temporal IAF, and posterior DFP-pre-alpha) achieving an AUC of 0.86, whereas anterior DFP-alpha alone achieved an AUC of 0.85.\nConclusion\n Among patients with LB disease, resting-state EEG features were associated with CF and were significant predictors of CF even after adjustment for age, sex, and MoCA. The development of an EEG-based biomarker of CF using this set of features could improve diagnosis of Lewy body dementia.\n                <\/p>","DOI":"10.21203\/rs.3.rs-9193762\/v1","type":"posted-content","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T06:44:48Z","timestamp":1774939488000},"source":"Crossref","is-referenced-by-count":0,"title":["Resting-State EEG Features of Cognitive Fluctuations Across the Lewy Body Disease Spectrum"],"prefix":"10.21203","author":[{"given":"Ahmed","family":"Negida","sequence":"first","affiliation":[{"name":"Virginia Commonwealth University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah K.","family":"Lageman","sequence":"additional","affiliation":[{"name":"Virginia Commonwealth University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenchiro","family":"Ono","sequence":"additional","affiliation":[{"name":"Virginia Commonwealth University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Moinul","family":"Ahsan","sequence":"additional","affiliation":[{"name":"Virginia Commonwealth University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitai","family":"Mukhopadhyay","sequence":"additional","affiliation":[{"name":"Virginia Commonwealth University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Barrett","sequence":"additional","affiliation":[{"name":"Virginia Commonwealth University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1212\/CON.0000000000001496","article-title":"Lewy Body Dementia","volume":"30","author":"Galvin JE","year":"2024","unstructured":"Galvin JE. Lewy Body Dementia. Continuum (Minneap Minn). 2024;30:1673\u201398. https:\/\/doi.org\/10.1212\/CON.0000000000001496.","journal-title":"Continuum (Minneap Minn)"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13195-018-0350-6","article-title":"Clinical prevalence of Lewy body dementia","volume":"10","author":"Kane JPM","year":"2018","unstructured":"Kane JPM, Surendranathan A, Bentley A, Barker SAH, Taylor J-P, Thomas AJ, et al. Clinical prevalence of Lewy body dementia. Alz Res Therapy. 2018;10:19. https:\/\/doi.org\/10.1186\/s13195-018-0350-6.","journal-title":"Alz Res Therapy"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1007\/s00415-011-5972-6","article-title":"How well do we recognise non-motor symptoms in a British Parkinson\u2019s disease population?","volume":"258","author":"Hu M","year":"2011","unstructured":"Hu M, Cooper J, Beamish R, Jones E, Butterworth R, Catterall L, et al. How well do we recognise non-motor symptoms in a British Parkinson\u2019s disease population? J Neurol. 2011;258:1513\u20137. https:\/\/doi.org\/10.1007\/s00415-011-5972-6.","journal-title":"J Neurol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.parkreldis.2010.03.007","article-title":"Lewy body dementia: the caregiver experience of clinical care","volume":"16","author":"Galvin JE","year":"2010","unstructured":"Galvin JE, Duda JE, Kaufer DI, Lippa CF, Taylor A, Zarit SH. Lewy body dementia: the caregiver experience of clinical care. Parkinsonism Relat Disord. 2010;16:388\u201392. https:\/\/doi.org\/10.1016\/j.parkreldis.2010.03.007.","journal-title":"Parkinsonism Relat Disord"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(19)30153-X","article-title":"New evidence on the management of Lewy body dementia","volume":"19","author":"Taylor J-P","year":"2020","unstructured":"Taylor J-P, McKeith IG, Burn DJ, Boeve BF, Weintraub D, Bamford C, et al. New evidence on the management of Lewy body dementia. Lancet Neurol Elsevier. 2020;19:157\u201369. https:\/\/doi.org\/10.1016\/S1474-4422(19)30153-X.","journal-title":"Lancet Neurol Elsevier"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2015.14121582","article-title":"Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis","author":"Stinton C","year":"2015","unstructured":"Stinton C, McKeith I, Taylor J-P, Lafortune L, Mioshi E, Mak E, et al. Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis. Am J Psychiatry [Internet] Am Psychiatric AssociationArlington. 2015. https:\/\/doi.org\/10.1176\/appi.ajp.2015.14121582. [cited 2026 Jan 8].","journal-title":"Am J Psychiatry [Internet] Am Psychiatric AssociationArlington"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-230173","article-title":"Non-Pharmacological Treatment of Autonomic Dysfunction in Parkinson\u2019s Disease and Other Synucleinopathies","author":"Palma J-A","year":"2023","unstructured":"Palma J-A, Thijs RD. Non-Pharmacological Treatment of Autonomic Dysfunction in Parkinson\u2019s Disease and Other Synucleinopathies. J Parkinsons Dis Neth. 2023. https:\/\/doi.org\/10.3233\/JPD-230173.","journal-title":"J Parkinsons Dis Neth"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith IG","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor J-P, Weintraub D, et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017;89:88\u2013100. https:\/\/doi.org\/10.1212\/WNL.0000000000004058.","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease","volume":"22","author":"Emre M","year":"2007","unstructured":"Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, et al. Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov Disord. 2007;22:1689\u2013707. https:\/\/doi.org\/10.1002\/mds.21507. quiz 1837.","journal-title":"Mov Disord"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/gps.368","article-title":"The characterisation and impact of \u2018fluctuating\u2019 cognition in dementia with Lewy bodies and Alzheimer\u2019s disease","volume":"16","author":"Ballard C","year":"2001","unstructured":"Ballard C, Walker M, O\u2019Brien J, Rowan E, McKeith I. The characterisation and impact of \u2018fluctuating\u2019 cognition in dementia with Lewy bodies and Alzheimer\u2019s disease. Int J Geriatr Psychiatry. 2001;16:494\u20138. https:\/\/doi.org\/10.1002\/gps.368.","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1001\/archneur.58.6.977","article-title":"Attention and fluctuating attention in patients with dementia with Lewy bodies and Alzheimer disease","volume":"58","author":"Ballard C","year":"2001","unstructured":"Ballard C, O\u2019Brien J, Gray A, Cormack F, Ayre G, Rowan E, et al. Attention and fluctuating attention in patients with dementia with Lewy bodies and Alzheimer disease. Arch Neurol. 2001;58:977\u201382. https:\/\/doi.org\/10.1001\/archneur.58.6.977.","journal-title":"Arch Neurol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e280","DOI":"10.1002\/gps.4788","article-title":"The association between cognitive fluctuations and activities of daily living and quality of life among institutionalized patients with dementia","volume":"33","author":"Sun M","year":"2018","unstructured":"Sun M, Mainland BJ, Ornstein TJ, Mallya S, Fiocco AJ, Sin GL, et al. The association between cognitive fluctuations and activities of daily living and quality of life among institutionalized patients with dementia. Int J Geriatr Psychiatry. 2018;33:e280\u20135. https:\/\/doi.org\/10.1002\/gps.4788.","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1177\/1533317515603359","article-title":"Assessing Fluctuating Cognition in Dementia Diagnosis","volume":"31","author":"Dyk K","year":"2016","unstructured":"Van Dyk K, Towns S, Tatarina O, Yeung P, Dorrejo J, Zahodne LB, et al. Assessing Fluctuating Cognition in Dementia Diagnosis. Am J Alzheimers Dis Other Demen. 2016;31:137\u201343. https:\/\/doi.org\/10.1177\/1533317515603359.","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14802\/jmd.19052","article-title":"Diagnostic Criteria for Dementia with Lewy Bodies: Updates and Future Directions","volume":"13","author":"Yamada M","year":"2020","unstructured":"Yamada M, Komatsu J, Nakamura K, Sakai K, Samuraki-Yokohama M, Nakajima K, et al. Diagnostic Criteria for Dementia with Lewy Bodies: Updates and Future Directions. J Mov Disord. 2020;13:1\u201310. https:\/\/doi.org\/10.14802\/jmd.19052.","journal-title":"J Mov Disord"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.clinph.2018.03.013","article-title":"Quantitative electroencephalography as a marker of cognitive fluctuations in dementia with Lewy bodies and an aid to differential diagnosis","volume":"129","author":"Stylianou M","year":"2018","unstructured":"Stylianou M, Murphy N, Peraza LR, Graziadio S, Cromarty R, Killen A, et al. Quantitative electroencephalography as a marker of cognitive fluctuations in dementia with Lewy bodies and an aid to differential diagnosis. Clin Neurophysiol. 2018;129:1209\u201320. https:\/\/doi.org\/10.1016\/j.clinph.2018.03.013.","journal-title":"Clin Neurophysiol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/brain\/awm322","article-title":"EEG comparisons in early Alzheimer\u2019s disease, dementia with Lewy bodies and Parkinson\u2019s disease with dementia patients with a 2-year follow-up","volume":"131","author":"Bonanni L","year":"2008","unstructured":"Bonanni L, Thomas A, Tiraboschi P, Perfetti B, Varanese S, Onofrj M. EEG comparisons in early Alzheimer\u2019s disease, dementia with Lewy bodies and Parkinson\u2019s disease with dementia patients with a 2-year follow-up. Brain. 2008;131:690\u2013705. https:\/\/doi.org\/10.1093\/brain\/awm322.","journal-title":"Brain"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13195-020-00650-1","article-title":"Quantitative EEG as a biomarker in mild cognitive impairment with Lewy bodies","volume":"12","author":"Schumacher J","year":"2020","unstructured":"Schumacher J, Taylor J-P, Hamilton CA, Firbank M, Cromarty RA, Donaghy PC, et al. Quantitative EEG as a biomarker in mild cognitive impairment with Lewy bodies. Alzheimer\u2019s Res Therapy. 2020;12:82. https:\/\/doi.org\/10.1186\/s13195-020-00650-1.","journal-title":"Alzheimer\u2019s Res Therapy"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.neurobiolaging.2014.07.009","article-title":"Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies","volume":"36","author":"Bonanni L","year":"2015","unstructured":"Bonanni L, Perfetti B, Bifolchetti S, Taylor J-P, Franciotti R, Parnetti L, et al. Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies. Neurobiol Aging. 2015;36:434\u201345. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.07.009.","journal-title":"Neurobiol Aging"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1159\/000017262","article-title":"Quantification and characterization of fluctuating cognition in dementia with Lewy bodies and Alzheimer\u2019s disease","volume":"11","author":"Walker MP","year":"2000","unstructured":"Walker MP, Ayre GA, Perry EK, Wesnes K, McKeith IG, Tovee M, et al. Quantification and characterization of fluctuating cognition in dementia with Lewy bodies and Alzheimer\u2019s disease. Dement Geriatr Cogn Disord. 2000;11:327\u201335. https:\/\/doi.org\/10.1159\/000017262.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma RB","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord. 2015;30:1591\u2013601. https:\/\/doi.org\/10.1002\/mds.26424.","journal-title":"Mov Disord"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.3233\/JAD-160435","article-title":"EEG Markers of Dementia with Lewy Bodies: A Multicenter Cohort Study","volume":"54","author":"Bonanni L","year":"2016","unstructured":"Bonanni L, Franciotti R, Nobili F, Kramberger MG, Taylor J-P, Garcia-Ptacek S, et al. EEG Markers of Dementia with Lewy Bodies: A Multicenter Cohort Study. J Alzheimers Dis. 2016;54:1649\u201357. https:\/\/doi.org\/10.3233\/JAD-160435.","journal-title":"J Alzheimers Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.18233964","article-title":"Negidamd\/negida-fe-toolbox: Initial public release [Internet]","author":"Negida A","year":"2026","unstructured":"Negida A. Negidamd\/negida-fe-toolbox: Initial public release [Internet]. Zenodo; 2026. https:\/\/doi.org\/10.5281\/zenodo.18233964"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3389\/fnagi.2018.00190","article-title":"EEG Characteristics of Dementia With Lewy Bodies, Alzheimer\u2019s Disease and Mixed Pathology","volume":"10","author":"Zande JJ","year":"2018","unstructured":"van der Zande JJ, Gouw AA, van Steenoven I, Scheltens P, Stam CJ, Lemstra AW. EEG Characteristics of Dementia With Lewy Bodies, Alzheimer\u2019s Disease and Mixed Pathology. Front Aging Neurosci. 2018;10:190. https:\/\/doi.org\/10.3389\/fnagi.2018.00190.","journal-title":"Front Aging Neurosci"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1093\/brain\/awz069","article-title":"Dysfunctional brain dynamics and their origin in Lewy body dementia","volume":"142","author":"Schumacher J","year":"2019","unstructured":"Schumacher J, Peraza LR, Firbank M, Thomas AJ, Kaiser M, Gallagher P, et al. Dysfunctional brain dynamics and their origin in Lewy body dementia. Brain. 2019;142:1767\u201382. https:\/\/doi.org\/10.1093\/brain\/awz069.","journal-title":"Brain"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.clinph.2015.06.020","article-title":"Neurophysiological biomarkers for Lewy body dementias","volume":"127","author":"Cromarty RA","year":"2016","unstructured":"Cromarty RA, Elder GJ, Graziadio S, Baker M, Bonanni L, Onofrj M, et al. Neurophysiological biomarkers for Lewy body dementias. Clin Neurophysiol. 2016;127:349\u201359. https:\/\/doi.org\/10.1016\/j.clinph.2015.06.020.","journal-title":"Clin Neurophysiol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3390\/diagnostics10090616","article-title":"The Role of EEG in the Diagnosis, Prognosis and Clinical Correlations of Dementia with Lewy Bodies\u2014A","volume":"10","author":"Law ZK","year":"2020","unstructured":"Law ZK, Todd C, Mehraram R, Schumacher J, Baker MR, LeBeau FEN, et al. The Role of EEG in the Diagnosis, Prognosis and Clinical Correlations of Dementia with Lewy Bodies\u2014A. Syst Rev Diagnostics (Basel). 2020;10:616. https:\/\/doi.org\/10.3390\/diagnostics10090616.","journal-title":"Syst Rev Diagnostics (Basel)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2023.1150540","article-title":"Quantitative EEG for early differential diagnosis of dementia with Lewy bodies","author":"Iannaccone S","year":"2023","unstructured":"Iannaccone S, Houdayer E, Spina A, Nocera G, Alemanno F. Quantitative EEG for early differential diagnosis of dementia with Lewy bodies. Front Psychol [Internet] Front. 2023. https:\/\/doi.org\/10.3389\/fpsyg.2023.1150540. [cited 2025 Feb 25];14.","journal-title":"Front Psychol [Internet] Front"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.neurobiolaging.2020.04.023","article-title":"Anterior EEG slowing in dementia with Lewy bodies: a multicenter European cohort study","volume":"93","author":"Franciotti R","year":"2020","unstructured":"Franciotti R, Pilotto A, Moretti DV, Falasca NW, Arnaldi D, Taylor J-P, et al. Anterior EEG slowing in dementia with Lewy bodies: a multicenter European cohort study. Neurobiol Aging. 2020;93:55\u201360. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2020.04.023.","journal-title":"Neurobiol Aging"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/brain\/awz311","article-title":"Cognitive fluctuations in Lewy body dementia: towards a pathophysiological framework","volume":"143","author":"Matar E","year":"2020","unstructured":"Matar E, Shine JM, Halliday GM, Lewis SJG. Cognitive fluctuations in Lewy body dementia: towards a pathophysiological framework. Brain. 2020;143:31\u201346. https:\/\/doi.org\/10.1093\/brain\/awz311.","journal-title":"Brain"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1212\/wnl.54.8.1616","article-title":"Quantifying fluctuation in dementia with Lewy bodies, Alzheimer\u2019s disease, and vascular dementia","volume":"54","author":"Walker MP","year":"2000","unstructured":"Walker MP, Ayre GA, Cummings JL, Wesnes K, McKeith IG, O\u2019Brien JT, et al. Quantifying fluctuation in dementia with Lewy bodies, Alzheimer\u2019s disease, and vascular dementia. Neurology. 2000;54:1616\u201325. https:\/\/doi.org\/10.1212\/wnl.54.8.1616.","journal-title":"Neurology"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"4637","DOI":"10.1038\/s41598-018-22984-5","article-title":"Electroencephalographic derived network differences in Lewy body dementia compared to Alzheimer\u2019s disease patients","volume":"8","author":"Peraza LR","year":"2018","unstructured":"Peraza LR, Cromarty R, Kobeleva X, Firbank MJ, Killen A, Graziadio S, et al. Electroencephalographic derived network differences in Lewy body dementia compared to Alzheimer\u2019s disease patients. Sci Rep Nat Publishing Group. 2018;8:4637. https:\/\/doi.org\/10.1038\/s41598-018-22984-5.","journal-title":"Sci Rep Nat Publishing Group"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41531-022-00279-x","article-title":"Dynamic network impairments underlie cognitive fluctuations in Lewy body dementia","volume":"8","author":"Matar E","year":"2022","unstructured":"Matar E, Ehgoetz Martens KA, Phillips JR, Wainstein G, Halliday GM, Lewis SJG, et al. Dynamic network impairments underlie cognitive fluctuations in Lewy body dementia. npj Parkinsons Dis Nat Publishing Group. 2022;8:16. https:\/\/doi.org\/10.1038\/s41531-022-00279-x.","journal-title":"npj Parkinsons Dis Nat Publishing Group"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"17562864211057666","DOI":"10.1177\/17562864211057666","author":"Armstrong MJ","year":"2021","unstructured":"Armstrong MJ, Ltd STM. 2021;14:17562864211057666. https:\/\/doi.org\/10.1177\/17562864211057666."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"113321","DOI":"10.1016\/j.bbr.2021.113321","article-title":"Altered functional connectivity between the nucleus basalis of Meynert and anterior cingulate cortex is associated with declined attentional performance after total sleep deprivation","volume":"409","author":"Qi J","year":"2021","unstructured":"Qi J, Li B-Z, Zhang Y, Pan B, Gao Y-H, Zhan H, et al. Altered functional connectivity between the nucleus basalis of Meynert and anterior cingulate cortex is associated with declined attentional performance after total sleep deprivation. Behav Brain Res. 2021;409:113321. https:\/\/doi.org\/10.1016\/j.bbr.2021.113321.","journal-title":"Behav Brain Res"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"116607","DOI":"10.1016\/j.neuroimage.2020.116607","article-title":"Cholinergic white matter pathways make a stronger contribution to attention and memory in normal aging than cerebrovascular health and nucleus basalis of Meynert","volume":"211","author":"Nemy M","year":"2020","unstructured":"Nemy M, Cedres N, Grothe MJ, Muehlboeck J-S, Lindberg O, Nedelska Z, et al. Cholinergic white matter pathways make a stronger contribution to attention and memory in normal aging than cerebrovascular health and nucleus basalis of Meynert. NeuroImage. 2020;211:116607. https:\/\/doi.org\/10.1016\/j.neuroimage.2020.116607.","journal-title":"NeuroImage"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1007\/s00415-014-7439-z","article-title":"Atrophy of the cholinergic basal forebrain in dementia with Lewy bodies and Alzheimer\u2019s disease dementia","volume":"261","author":"Grothe MJ","year":"2014","unstructured":"Grothe MJ, Schuster C, Bauer F, Heinsen H, Prudlo J, Teipel SJ. Atrophy of the cholinergic basal forebrain in dementia with Lewy bodies and Alzheimer\u2019s disease dementia. J Neurol. 2014;261:1939\u201348. https:\/\/doi.org\/10.1007\/s00415-014-7439-z.","journal-title":"J Neurol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1093\/brain\/awab372","article-title":"Cholinergic white matter pathways in dementia with Lewy bodies and Alzheimer\u2019s disease","volume":"145","author":"Schumacher J","year":"2022","unstructured":"Schumacher J, Ray NJ, Hamilton CA, Donaghy PC, Firbank M, Roberts G, et al. Cholinergic white matter pathways in dementia with Lewy bodies and Alzheimer\u2019s disease. Brain. 2022;145:1773\u201384. https:\/\/doi.org\/10.1093\/brain\/awab372.","journal-title":"Brain"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"4549","DOI":"10.1002\/alz.13034","article-title":"Free water imaging of the cholinergic system in dementia with Lewy bodies and Alzheimer\u2019s disease","volume":"19","author":"Schumacher J","year":"2023","unstructured":"Schumacher J, Ray NJ, Hamilton CA, Bergamino M, Donaghy PC, Firbank M, et al. Free water imaging of the cholinergic system in dementia with Lewy bodies and Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2023;19:4549\u201363. https:\/\/doi.org\/10.1002\/alz.13034.","journal-title":"Alzheimer\u2019s Dement"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/brain\/awx310","article-title":"In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson\u2019s disease","volume":"141","author":"Ray NJ","year":"2018","unstructured":"Ray NJ, Bradburn S, Murgatroyd C, Toseeb U, Mir P, Kountouriotis GK, et al. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson\u2019s disease. Brain. 2018;141:165\u201376. https:\/\/doi.org\/10.1093\/brain\/awx310.","journal-title":"Brain"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2967\/jnumed.116.176180","article-title":"123I-Iodobenzovesamicol SPECT Imaging of Cholinergic Systems in Dementia with Lewy Bodies","volume":"58","author":"Maz\u00e8re J","year":"2017","unstructured":"Maz\u00e8re J, Lamare F, Allard M, Fernandez P, Mayo W. 123I-Iodobenzovesamicol SPECT Imaging of Cholinergic Systems in Dementia with Lewy Bodies. J Nuclear Med Soc Nuclear Med. 2017;58:123\u20138. https:\/\/doi.org\/10.2967\/jnumed.116.176180.","journal-title":"J Nuclear Med Soc Nuclear Med"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1212\/WNL.0b013e3181ab2b58","article-title":"Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET","volume":"73","author":"Shimada H","year":"2009","unstructured":"Shimada H, Hirano S, Shinotoh H, Aotsuka A, Sato K, Tanaka N, et al. Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET. Neurol Wolters Kluwer. 2009;73:273\u20138. https:\/\/doi.org\/10.1212\/WNL.0b013e3181ab2b58.","journal-title":"Neurol Wolters Kluwer"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.neurobiolaging.2022.04.001","article-title":"Reactivity of posterior cortical electroencephalographic alpha rhythms during eyes opening in cognitively intact older adults and patients with dementia due to Alzheimer\u2019s and Lewy body diseases","volume":"115","author":"Babiloni C","year":"2022","unstructured":"Babiloni C, Lorenzo I, Lizio R, Lopez S, Tucci F, Ferri R, et al. Reactivity of posterior cortical electroencephalographic alpha rhythms during eyes opening in cognitively intact older adults and patients with dementia due to Alzheimer\u2019s and Lewy body diseases. Neurobiol Aging. 2022;115:88\u2013108. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2022.04.001.","journal-title":"Neurobiol Aging"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13195-020-00613-6","article-title":"EEG alpha reactivity and cholinergic system integrity in Lewy body dementia and Alzheimer\u2019s disease","volume":"12","author":"Schumacher J","year":"2020","unstructured":"Schumacher J, Thomas AJ, Peraza LR, Firbank M, Cromarty R, Hamilton CA, et al. EEG alpha reactivity and cholinergic system integrity in Lewy body dementia and Alzheimer\u2019s disease. Alzheimers Res Ther Engl. 2020;12:46. https:\/\/doi.org\/10.1186\/s13195-020-00613-6.","journal-title":"Alzheimers Res Ther Engl"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2021.728405","article-title":"Abnormalities of Resting-State Electroencephalographic Microstate in Rapid Eye Movement Sleep Behavior Disorder","author":"Peng A","year":"2021","unstructured":"Peng A, Wang R, Huang J, Wu H, Chen L. Abnormalities of Resting-State Electroencephalographic Microstate in Rapid Eye Movement Sleep Behavior Disorder. Front Hum Neurosci [Internet]. Frontiers; 2021 [cited 2025 Nov 16];15. https:\/\/doi.org\/10.3389\/fnhum.2021.728405"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.998224","article-title":"Predictors of response to acetylcholinesterase inhibitors in dementia: A systematic review","author":"Pozzi FE","year":"2022","unstructured":"Pozzi FE, Conti E, Appollonio I, Ferrarese C, Tremolizzo L. Predictors of response to acetylcholinesterase inhibitors in dementia: A systematic review. Front Neurosci [Internet] Front. 2022. https:\/\/doi.org\/10.3389\/fnins.2022.998224. [cited 2025 Nov 17];16.","journal-title":"Front Neurosci [Internet] Front"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"CD006504","DOI":"10.1002\/14651858.CD006504.pub2","article-title":"Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson\u2019s disease dementia and cognitive impairment in Parkinson\u2019s disease","volume":"2012","author":"Rolinski M","year":"2012","unstructured":"Rolinski M, Fox C, Maidment I, McShane R. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson\u2019s disease dementia and cognitive impairment in Parkinson\u2019s disease. Cochrane Database Syst Rev. 2012;2012:CD006504. https:\/\/doi.org\/10.1002\/14651858.CD006504.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"e70136","DOI":"10.1002\/trc2.70136","article-title":"Patterns and predictors of cholinesterase inhibitor use in dementia with Lewy bodies","volume":"11","author":"Heo RJ","year":"2025","unstructured":"Heo RJ, Negida A, Wyman-Chick KA, Bateman JR, Rodriguez-Porcel F, Berman BD, et al. Patterns and predictors of cholinesterase inhibitor use in dementia with Lewy bodies. Alzheimers Dement (N Y). 2025;11:e70136. https:\/\/doi.org\/10.1002\/trc2.70136.","journal-title":"Alzheimers Dement (N Y)"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/00002826-200309000-00008","article-title":"The effects of a cholinesterase inhibitor are prominent in patients with fluctuating cognition: a part 3 study of the main mechanism of cholinesterase inhibitors in dementia","volume":"26","author":"Onofrj M","year":"2003","unstructured":"Onofrj M, Thomas A, Iacono D, Luciano AL, Di Iorio A. The effects of a cholinesterase inhibitor are prominent in patients with fluctuating cognition: a part 3 study of the main mechanism of cholinesterase inhibitors in dementia. Clin Neuropharmacol. 2003;26:239\u201351. https:\/\/doi.org\/10.1097\/00002826-200309000-00008.","journal-title":"Clin Neuropharmacol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.clinph.2009.03.004","article-title":"Cholinergic modulation of MEG resting-state oscillatory activity in Parkinson\u2019s disease related dementia","volume":"120","author":"Bosboom JLW","year":"2009","unstructured":"Bosboom JLW, Stoffers D, Stam CJ, Berendse HW, Wolters EC. Cholinergic modulation of MEG resting-state oscillatory activity in Parkinson\u2019s disease related dementia. Clin Neurophysiol Neth. 2009;120:910\u20135. https:\/\/doi.org\/10.1016\/j.clinph.2009.03.004.","journal-title":"Clin Neurophysiol Neth"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10072-023-07114-y","article-title":"The effects of different acetylcholinesterase inhibitors on EEG patterns in patients with Alzheimer\u2019s disease: A systematic review","volume":"45","author":"Arjmandi-Rad S","year":"2024","unstructured":"Arjmandi-Rad S, Vestergaard Nieland JD, Goozee KG, Vaseghi S. The effects of different acetylcholinesterase inhibitors on EEG patterns in patients with Alzheimer\u2019s disease: A systematic review. Neurol Sci. 2024;45:417\u201330. https:\/\/doi.org\/10.1007\/s10072-023-07114-y.","journal-title":"Neurol Sci"},{"key":"ref51","unstructured":"Supplementary Table 1. Logistic Regression Analysis of EEG features predicting LB disease with CF after adjusting for age, sex, and MoCA score."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9193762\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9193762\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:16:23Z","timestamp":1785168983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9193762\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":51,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-9193762\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1186\/s13195-026-02148-8","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2026,3,31]]},"subtype":"preprint"}}